Company intelligence / Profile preview

Hainan Poly Pharmaceutical

Haikou, Hainan, China

Ownership: Private
Employees: ~1600
Development stage: Other

Overview

Hainan Poly Pharmaceutical is a major Chinese pharmaceutical company specializing in high-end generic drugs and complex injectables. It is notable for having multiple manufacturing lines certified by the FDA, EMA, and WHO, allowing it to export products to highly regulated international markets. Its clinical focus is on infectious diseases, contrast agents for imaging, and CNS disorders.

Therapeutic areas: OtherCardiovascularNeurologyInfectious DiseasesOncology
Modalities: Small moleculeContrast agent
Industry: Biotech

Partnerships

Hikma PharmaceuticalsSagent Pharmaceuticals

Beyond the preview

Go deeper on Hainan Poly Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hainan Poly Pharmaceutical.

Explore the full profile